Jiangsu Intco Medical Products Co., Ltd.FDA
- FEI
- 3005260401
- Record date
- Establishment
- OTC Drug Manufacturer
- Location
- China
Every published Form FDA 483 issued in November 2023, drawn from the FDA OII FOIA Electronic Reading Room. Each row links to the FDA source record.
9
Published 483s in November 2023
9
Distinct firms
| Company | FEI | Establishment type | Location | FDA date | Source |
|---|---|---|---|---|---|
| Jiangsu Intco Medical Products Co., Ltd. | 3005260401 | OTC Drug Manufacturer | China | FDA | |
| Daizo Corporation | 3008470621 | OTC Drug Manufacturer | Japan | FDA | |
| Takeda Pharmaceutical Company Limited | 3004664162 | Human Drug Manufacturer | Japan | FDA | |
| Nanchang Anobri Pharmaceutical Co., Ltd. | 3023765884 | Finished Pharmaceutical Manufacturer | China | FDA | |
| C&T Dream Co., Ltd. | 3012668529 | Finished Pharmaceutical Manufacturer | Republic of Korea | FDA | |
| Contract Pharmaceuticals Limited Canada | 3001581899 | Finished Pharmaceutical Manufacturer | Canada | FDA | |
| Catalent Indiana, LLC | 3005949964 | Manufacturer | Indiana, United States | FDA | |
| Wedgewood Connect, LLC | 3003434972 | Outsourcing Facility | California, United States | FDA | |
| Hybrid Pharma LLC | 3011319445 | Outsourcing Facility | Florida, United States | FDA |